Groww Logo

Biogen Pharmachem Industries Financial Statements

Quarterly
Yearly
ParticularsMar '21Jun '21Sep '21Dec '21Mar '22
Revenue1.621.251.220.000.00
Expenses3.111.051.050.020.06
EBITDA-1.490.200.17-0.02-0.06
EBIT-1.490.200.17-0.02-0.06
Profit Before Tax0.620.200.010.01-0.23
Net Profit0.620.200.010.01-0.23
Financial Ratios
Operating Profit Margin-91.36%16.00%14.75%NA%NA%
Net Profit Margin38.27%16.00%0.82%NA%NA%
Earning Per Share (Diluted)0.010.000.000.00-0.00
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.1.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI